Inventiva S.A. ADR (IVA) Social Stream
INVENTIVA SA (IVA) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering INVENTIVA SA.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
IVA's average price target has moved down $3.5 over the prior 24 months.
Over the past 141 days, IVA's average upside potential has been 419.6%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
IVA Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 25 months, IVA's average broker recommendation rating worsened by 1.11.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- IVA has a higher upside potential (average analyst target price relative to current price) than 1116.3% of all US stocks.
- In terms of how INVENTIVA SA fares relative to all US stocks, note that its number of analysts covering the stock is greater than 124.57% of that group.
- In terms of how INVENTIVA SA fares relative to stocks in the small market cap category, note that its variance in analysts' estimates is lower than -773.96% of that group.
- IVA has a higher average analyst price target than 837.54% of stocks in the small market cap category.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to INVENTIVA SA are ANNX, NRIX, and INZY.
View All Top Stocks by Price Target
Is IVA a Buy, Hold or Sell? See the POWR Ratings now!